NEW YORK, May 19, 2020 /PRNewswire/ – Arria NLG, a leading provider of Natural Language Generation (NLG) technology, today announced a collaboration with Glemser Technologies to bring scalable automation solutions and major efficiencies to healthcare and pharmaceuticals companies. Glemser will augment its global Life Sciences Practice with a Natural Language Generation solution powered by Arria technologies.
“Partnering with Arria to provide our clients with a way to automate the writing of medical and regulatory reports was a natural choice,” says Ray Glemser, CEO. “NLG allows companies to save significant time and money while increasing scalability and efficiency. Arria’s break-through technology will transform the way our customers bring life-saving drugs to market.”
By automating some of the most time-consuming reporting—such as Clinical Safety Reports (CSRs), Compliance Reports, Adverse Event Detection, and other regulatory reports—firms can reap cost savings and free their medical writers from the tedious work that is most prone to human error. Faster reporting means they can present findings to regulatory authorities more quickly. Improved accuracy early on in the reporting process means better compliance and faster regulatory approval. …
READ FULL ANNOUNCEMENT > Morningstar | Yahoo! Finance
VIEW THE NEW PARTNER PORTAL > Glemser + Arria Portal
